Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Equity Capital Markets

Genoray is an IPO in Korea that is scheduled to be completed in May 2018. Genoray is a medical &amp; dental imaging equipment maker in Korea. The IPO deal size is expected to be between US$10 million to US$11 million. Korea Investment &amp; Securities is the lead banker on this deal. The expected market cap of the company using the IPO price range is between 83 billion won and 97 billion won. Despite the low market cap, there is likely to be some interest in this IPO by many institutional investors…

Genoray is an IPO in Korea that is scheduled to be completed in May 2018. Genoray is a medical &amp; dental imaging equipment maker in Korea. The IPO deal size is expected to be between US$10 million to US$11 million. Korea Investment &amp; Securities is the lead banker on this deal. The expected market cap of the company using the IPO price range is between 83 billion won and 97 billion won. Despite the low market cap, there is likely to be some interest in this IPO by many institutional investors…

Genoray IPO Preview (Part 1) - Better than Sejong Medical IPO?

South Korea

Vieworks Company Ltd. designs and manufactures camera systems for digital radiography, digital fluoroscopy, and angiography systems.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Vieworks Co Ltd (100120 KS)

Genoray IPO Preview (Part 1) - Better than Sejong Medical IPO?

Genoray is an IPO in Korea that is scheduled to be completed in May 2018. Genoray is a medical & dental imaging equipment maker in Korea. The...

Douglas Kim

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)